- MVT
top of page
Search
PR.com-Press-Release_ID David Lim
.pdf
Download PDF • 16KB
Recent Posts
See AllMicrovascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum [Tucson, AZ] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company pioneering the developmen
3030
[Tucson, Arizona] – [2/05/2024] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic p
850
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the prestigious H7 Healthcare Accelerator
2780
bottom of page